Role of intranasal midazolam as a procedural sedative in children aged 6 months to 12 years: An open-label randomized controlled study. Indian J Child Health [Internet]. 2018 Jan. 25 [cited 2024 Nov. 22];5(1):1-5. Available from: https://mansapublishers.com/index.php/ijch/article/view/678